Cover Image
Market Research Report

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

Published by MarketsandMarkets Product code 608818
Published Content info 138 Pages
Delivery time: 1-2 business days
Price
Back to Top
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022
Published: February 27, 2018 Content info: 138 Pages
Description

"The injection pen market is projected to grow at a CAGR of 6.0% during the forecast period"

The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.

"By type, the disposable injection pens segment is expected to grow at the highest rate during the forecast period (2017-2022)."

Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.

"By therapy, the diabetes segment is expected to grow at the highest CAGR during the study period."

Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.

"The North American injection pen market is expected to grow at the highest CAGR during the forecast period"

North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-50%, Tier 2-30% and Tier 3-20%
  • By Designation - C-level-30%, Director Level-48%, Others-22%
  • By Region - North America-48%, Europe-20%, Asia Pacific-25%, Row-7%

The key players in the global injection pen market are: Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).

Research Coverage:

The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the injection pen market. The report analyzes the market based on type, therapy, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the injection pen market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various injection pens across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the injection pen market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market
Table of Contents
Product Code: MD 6041

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
  • 2.2. RESEARCH APPROACH
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL INJECTION PEN MARKET OVERVIEW
  • 4.2. GLOBAL INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022
  • 4.3. GEOGRAPHIC ANALYSIS: GLOBAL INJECTION PEN MARKET, BY THERAPY
  • 4.4. GLOBAL INJECTION PEN MARKET, BY END USER, 2017 VS. 2022
  • 4.5. GEOGRAPHIC SNAPSHOT: GLOBAL INJECTION PEN MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of chronic diseases
      • 5.2.1.2. Increasing number of regulatory approvals
      • 5.2.1.3. Favorable reimbursement and government support
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Preference for alternative drug delivery modes
      • 5.2.2.2. Poor reimbursement scenario in developing countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Patent expiry of biologics to drive the demand for biosimilars
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Needle-stick injuries & misuse of injection pen

6. INJECTION PEN MARKET, BY TYPE

  • 6.1. INTRODUCTION
    • 6.1.1. DISPOSABLE INJECTION PEN
    • 6.1.2. REUSABLE INJECTION PEN

7. INJECTION PEN MARKET, BY THERAPY

  • 7.1. INTRODUCTION
  • 7.2. DIABETES
    • 7.2.1. INSULIN
    • 7.2.2. GLUCAGON-LIKE PEPTIDE-1(GLP-1)
  • 7.3. GROWTH HORMONE THERAPY
  • 7.4. OSTEOPOROSIS
  • 7.5. FERTILITY
  • 7.6. OTHER THERAPIES

8. INJECTION PEN MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOME CARE
  • 8.3. HOSPITALS & CLINICS

9. INJECTION PEN MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. UK
    • 9.3.2. GERMANY
    • 9.3.3. FRANCE
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. ROAPAC
  • 9.5. ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. MARKET RANKING OF OEM COMPANIES
  • 10.4. COMPETITIVE SCENARIO
    • 10.4.1. PRODUCT LAUNCHES
    • 10.4.2. REGULATORY APPROVALS
    • 10.4.3. EXPANSIONS
    • 10.4.4. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.4.5. ACQUISITIONS

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1. NOVO NORDISK
  • 11.2. SANOFI
  • 11.3. ELI LILLY AND COMPANY
  • 11.4. MERCK
  • 11.5. YPSOMED
  • 11.6. ASTRAZENECA
  • 11.7. F.HOFFMAN-LA ROCHE
  • 11.8. BECTON, DICKINSON AND COMPANY (BD)
  • 11.9. OWEN MUMFORD
  • 11.11. NOVARTIS
  • 11.12. PFIZER
  • 11.13. HASELMEIER

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 2: DISPOSABLE INJECTION PEN MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 3: REUSABLE INJECTION PEN MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 4: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 5: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: INJECTION PEN MARKET FOR DIABETES THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: INJECTION PEN MARKET FOR INSULIN THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: INJECTION PEN MARKET FOR GLP-1 THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: INJECTION PEN MARKET FOR GROWTH HORMONE THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: INJECTION PEN MARKET FOR OSTEOPOROSIS THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: INJECTION PEN MARKET FOR FERTILITY THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: INJECTION PEN MARKET FOR OTHER THERAPIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 14: INJECTION PEN MARKET FOR HOME CARE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: INJECTION PEN MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: INJECTION PEN MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA: INJECTION PEN MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 22: FDA APPROVALS OF INJECTION PEN (2014-2017)
  • TABLE 23: US: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 24: US: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 25: US: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 26: US: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: CANADA: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: CANADA: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 29: CANADA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: CANADA: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: APPROVALS OF INJECTION PEN (2014-2017)
  • TABLE 32: EUROPE: INJECTION PEN MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: EUROPE: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 35: EUROPE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: UK: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: UK: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 39: UK: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: UK: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: GERMANY: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: GERMANY: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 43: GERMANY: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: FRANCE: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: FRANCE: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 47: FRANCE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: FRANCE: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: ROE: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: ROE: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 51: ROE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: ROE: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: ASIA PACIFIC: INJECTION PEN MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: CHINA: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: CHINA: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 60: CHINA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: CHINA: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 62: JAPAN: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: JAPAN: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 64: JAPAN: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: JAPAN: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: INDIA: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: INDIA: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 68: INDIA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: INDIA: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: ROAPAC: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: ROAPAC: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 72: ROAPAC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: ROAPAC: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 74: ROW: INJECTION PEN MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ROW: INJECTION PEN MARKET, BY THERAPY, 2015-2022 (USD MILLION)
  • TABLE 76: ROW: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ROW: INJECTION PEN MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 78: PRODUCT LAUNCHES
  • TABLE 79: REGULATORY APPROVALS
  • TABLE 80: EXPANSIONS
  • TABLE 81: AGREEMENTS AND PARTNERSHIPS
  • TABLE 82: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: GLOBAL INJECTION PEN MARKET
  • FIGURE 2: GLOBAL INJECTION PEN MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: SAMPLING FRAME: PRIMARY INSIGHTS
  • FIGURE 4: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: PRIMARY SOURCES
  • FIGURE 6: KEY INDUSTRY INSIGHTS
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9: DATA TRIANGULATION METHODOLOGY
  • FIGURE 10: DISPOSABLE INJECTION PEN DOMINATED THE MARKET IN 2017
  • FIGURE 11: DIABETES SEGMENT DOMINATED THE INJECTION PEN MARKET, BY THERAPY (2017)
  • FIGURE 12: INSULIN SEGMENT DOMINATED THE GLOBAL INJECTION PEN MARKET FOR DIABETES, BY TYPE (2017)
  • FIGURE 13: HOME CARE SEGMENT DOMINATED THE INJECTION PEN MARKET, BY END USER (2017)
  • FIGURE 14: NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: GROWING PREVALENCE OF CHRONIC DISEASES, INCREASING NUMBER OF REGULATORY APPROVALS, AND FAVORABLE REIMBURSEMENT AND GOVERNMENT SUPPORT ARE DRIVING MARKET GROWTH
  • FIGURE 16: DISPOSABLE INJECTION PEN SEGMENT DOMINATED THE MARKET IN 2017
  • FIGURE 17: DIABETES THERAPY DOMINATED THE GLOBAL INJECTION PEN MARKET IN 2017
  • FIGURE 18: HOME CARE ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 19: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 20: INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: INJECTION PEN MARKET, BY THERAPY, 2017 VS. 2022 (USD MILLION)
  • FIGURE 22: INJECTION PEN MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 23: NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 24: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 25: EUROPE: MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 27: ROW: MARKET SNAPSHOT
  • FIGURE 28: INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 29: GLOBAL INJECTION PEN MARKET RANKING BY OEM COMPANIES (AS OF 2016)
  • FIGURE 30: STRATEGIES ADOPTED BY MARKET PLAYERS (2014-2018)
  • FIGURE 31: NOVO NORDISK: COMPANY SNAPSHOT (2016)
  • FIGURE 32: SANOFI: COMPANY SNAPSHOT (2016)
  • FIGURE 33: ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 34: MERCK: COMPANY SNAPSHOT (2016)
  • FIGURE 35: YPSOMED: COMPANY SNAPSHOT (2016)
  • FIGURE 36: ASTRAZENECA: COMPANY SNAPSHOT (2016)
  • FIGURE 37: F.HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2016)
  • FIGURE 38: BD: COMPANY SNAPSHOT (2016)
  • FIGURE 39: NOVARTIS: COMPANY SNAPSHOT (2016)
  • FIGURE 40: PFIZER: COMPANY SNAPSHOT (2016)
Back to Top